bioRxiv Science⌕ Search

Biology subjects

Bian, H.

Publications and source records attributed to Bian, H..

13 recordsLinked to original sources

CellTok: Early-Fusion Multimodal Large Language Model for Single-Cell Transcriptomics via Tokenization

Large language models (LLMs) can process diverse forms of information once they are represented as tokens in a shared sequence space. However, single-cell transcriptomes remain a foreign modality to LLMs because they are continuous, high-dimensional molecular profiles rather than discrete linguistic units. Here, we propose CellTok, a tokenized single-cell language modeling approach that converts transcriptomic profiles into compact cellular token sequences and incorporates them into the vocabulary of a pretrained LLM. By representing cells as native tokens, CellTok enables cellular measurements, textual instructions, biological context, and multi-cell populations to be jointly processed within the same autoregressive modeling framework. Across diverse tasks, CellTok enable LLMs to recognize individual cells, interpret homogeneous and heterogeneous cell populations, infer disease-associated cellular states, predict cell-cell communication, model developmental trajectories, and generate cellular states. Moreover, prompt-based experiments show that providing appropriate biological context improves performance, indicating that CellTok can leverage LLM knowledge and contextual reasoning to support cellular data interpretation. These results demonstrate that single-cell transcriptomes can be transformed from a foreign molecular modality into a native language for LLMs, establishing a unified interface for modeling cells, populations, and biological knowledge in a shared token space.

bioinformatics↗

De Novo sequencing-assisted homology search for DIA data analysis enables low abundance peptide variants discovery

Data-independent acquisition mass spectrometry (DIA-MS) has emerged as a powerful approach for comprehensive proteome profiling. Spectral library search and library-free search are the two major approaches for DIA data analysis. The spectral library search requires high-quality spectral libraries derived from the search results of data-dependent acquisition (DDA) experiments, while library-free approaches rely on prediction models to generate in silico libraries. Both methodologies constrain the search space to the peptide list in the database, limiting the discovery of variant peptides arising from genetic variations or mutations. We present a novel computational method DIAVariant designed to identify peptide sequence variants directly and solely from complex DIA spectra while rigorously controlling the false discovery rate. Our experimental results demonstrate that DIAVariant successfully identifies sequence variants previously detected through proteogenomic approaches, while maintaining high specificity across multiple datasets. When integrated with existing DIA database search solutions, our approach constitutes a comprehensive analytical workflow capable of identifying peptides both represented within reference protein databases and those arising from sequence variations not captured in standard databases.

bioinformatics↗

GeST: Towards Building A Generative Pretrained Transformer for Learning Cellular Spatial Context

Learning spatial context of cells through pretraining on spatial transcriptomics (ST) data may empower us to systematically decipher tissue organization and cellular interactions. Yet, transformer-based generative models often focus on modeling individual cells, neglecting the intricate spatial relationships within them. We develop GeST, a deep transformer model that is pretrained by a novel spatially informed generation task: Predict cellular expression profile of a given location based on the information from its neighboring cells. We propose a spatial attention mechanism for efficient pretraining, a flexible serialization strategy for converting ST data into sequences, and a cell tokenization method for quantizing gene expression profiles. We pretrained GeST on large-scale ST datasets of different ST technologies and demonstrated its superior performance in generating unseen spatial cells. Our results also show that GeST can extract spatial niche embeddings in a zero-shot way and can be further fine-tuned for spatial annotation tasks. Furthermore, GeST can simulate gene expression changes in response to perturbations of cells within spatial context, closely matching existing experimental results. Overall, GeST offers a powerful generative pre-training framework for learning spatial contexts in spatial transcriptomics.

bioinformatics↗

Benchmarking AI Models for In Silico Gene Perturbation of Cells

Understanding perturbations at the single-cell level is essential for unraveling cellular mechanisms and their implications in health and disease. The growing availability of biological data has driven the development of a variety of in silico perturbation methods designed for single-cell analysis, which offer a means to address many inherent limitations of experimental approaches. However, these computational methods are often tailored to specific scenarios and validated on limited datasets and metrics, making their evaluation and comparison challenging. In this work, we introduce a comprehensive benchmarking framework to systematically evaluate in silico perturbation methods across four key scenarios: predicting effects of unseen perturbations in known cell types, predicting effects of observed perturbations in unseen cell types, zero-shot transfer to bulk RNA-seq of cell lines, and application to real-world biological cases. For each scenario, we curated diverse and abundant datasets, standardizing them into flexible formats to enable efficient analysis. Additionally, we developed multiple metrics tailored to each scenario, facilitating a thorough and comparative evaluation of these methods. Our benchmarking study assessed 10 methods, ranging from linear baselines to advanced machine learning approaches, across these scenarios. While some methods demonstrated surprising efficacy in specific contexts, significant challenges remain, particularly in zero-shot predictions and the modeling of complex biological processes. This work provides a valuable resource for evaluating and improving in silico perturbation methods, serving as a foundation for bridging computational predictions with experimental validation and real-world biological applications.

bioinformatics↗

scMulan: a multitask generative pre-trained language model for single-cell analysis

Cells can be viewed as complex stories written by coordinated expression of genes. The success of AI large language models (LLMs) in mastering the human language inspired us to develop a large AI model scMulan with 368 million parameters to generate cell transcriptomics with designated attributes by learning the cell language. We defined a unified c-sentence to incorporate cell transcriptomics and meta-attributes, and pre-trained scMulan on the equivalence of 100 million human cells. Experiments showed that scMulan can generate designated pseudo transcriptomics, predict missing attributes of cells, reconstruct unobserved cells along functional gradients, and can help to identify driving regulators of cell fates. The generated data passed tests of current tools and can reflect the underlying biology.

bioinformatics↗

scDirect: key transcription factor identification for directing cell state transitions based on single-cell multi-omics data

Cell state transitions are complicated processes that occur in various life activities. Understanding and artificially manipulating them have been longstanding challenges. Substantial experiments reveal that the transitions could be directed by several key transcription factors (TFs). Here we present scDirect, a computational framework to identify key TFs based on single-cell RNA-seq and ATAC-seq data. scDirect models the TF identification task as a linear inverse problem, and solve it with gene regulatory networks enhanced by a graph attention network. Through a benchmarking on a single-cell human embryonic stem cell atlas, we demonstrate the robustness and superiority of scDirect against alternative analysis methods on TF identification. We apply scDirect on various datasets, and scDirect exhibits high capability in identifying key TFs in cell differentiation and somatic cell conversion. Furthermore, scDirect can efficiently identify TF combinations for cell reprogramming, many of which have been experimentally validated. We envision that scDirect can utilize rapidly increasing single-cell datasets to identify key TFs for directing cell state transitions and may become an effective tool to facilitate cell engineering and regenerative medicine.

bioinformatics↗

Efficient inhibition of cell proliferation and promotion of apoptosis requires continuous treatment with abemaciclib.

Abemaciclib is an oral, selective cyclin-dependent kinase 4 & 6 inhibitor (CDK4 & 6i), approved for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) as monotherapy for endocrine refractory disease, and with endocrine therapy (ET) for initial treatment and after progression on ET. Abemaciclib has also shown clinical activity in combination with ET in patients with high risk early BC (EBC). Here, we examined the preclinical attributes of abemaciclib and other CDK4 & 6i using biochemical and cell-based assays. In vitro, abemaciclib preferentially inhibited CDK4 kinase activity versus CDK6, resulting in inhibition of cell proliferation in a panel of BC cell lines with higher average potency than palbociclib or ribociclib. Abemaciclib showed activity regardless of HER2 amplification and phosphatidylinositol 3-kinase (PI3KCA) gene mutation status. In human bone marrow progenitor cells, abemaciclib showed lower impact on myeloid maturation than other CDK4 & 6i when tested at unbound concentrations similar to those observed in clinical trials. Continuous abemaciclib treatment provided profound inhibition of cell proliferation, and triggered senescence and apoptosis. These preclinical results support the unique efficacy and safety profile of abemaciclib observed in clinical trials.

cell biology↗

Rice LEAFY COTYLEDON1 hinders photosynthesis in the embryo development to promote seed dormancy

LEAFY COTYLEDON1 (LEC1) is the central regulator of seed development. During seed development, rice embryo photosynthesis is completely blocked, which is different from Arabidopsis green embryo. However, effects of LEC1 on photosynthesis in developing seeds is largely elusive. We generated OsLEC1 mutants using the CRISPR/Cas9 technique. Oslec1 mutant seeds lost the ability of dormancy and triggered photosynthesis in embryos at the early developing stage. Transcriptome analysis demonstrated that Oslec1 mutation promoted photosynthesis and altered diverse hormonal pathways and stress response contributing to seed dormancy. Further, genome-wide identification of OsLEC1 binding sites demonstrated that OsLEC1 directly bound to genes involved in photosynthesis, photomorphogenesis, as well as abscisic acid (ABA) and gibberellin (GA) pathways, in seed maturation. We illustrated an OsLEC1-controlling gene network during seed development, including the interconnection between photosynthesis and ABA/GA biosynthesis/signalling. Our findings suggested that OsLEC1 is an inhibitor of photosynthesis during embryo development to promote rice seed maturation. This study would provide new understanding for the OsLEC1 regulatory mechanisms on photosynthesis in the monocot seed development.

plant biology↗

A human ensemble cell atlas (hECA) enables in data cell sorting

Single-cell omics data can characterize multifaceted features of massive cells and bring significant insights to biomedical researches. The accumulation of single-cell data provides growing resources for constructing atlases for all cells of a human organ or the whole body. The true assembly of a cell atlas should be cell-centric rather than file-centric. We proposed a unified information framework enabling seamless cell-centric data assembly and developed a human Ensemble Cell Atlas (hECA) as an instance. hECA version 1.0 assembled scRNA-seq data across multiple studies into one orchestrated data repository. It contains 1,093,299 labeled cells and metadata from 116 published human single-cell studies, covering 38 human organs and 11 systems. We invented three methods of applications based on the cell-centric assembly: "In data" cell sorting enables targeted data retrieval in the full atlas with customizable logic expressions; The "quantitative portraiture" system provides a multi-view presentation of biological entities (organs, cell types, and genes) of multiple granularities; The customizable reference creation allows users to use the cell-centric assembly to generate references for their own cell type annotations. Case studies on agile construction of user-defined sub-atlases and "in data" investigation of CAR-T off-targets in multiple organs showed the great potential of cell-centric atlas assembly.

bioinformatics↗

CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 variants

SARS-CoV-2 and its variants are raging worldwide. Unfortunately, the global vaccination is not efficient enough to attain a vaccine-based herd-immunity and yet no special and effective drug is developed to contain the spread of the disease. Previously we have identified CD147 as a novel receptor for SARS-CoV-2 infection. Here, we demonstrated that CD147 antibody effectively inhibits infection and cytokine storm caused by SARS-CoV-2 variants. In CD147KO VeroE6 cells, infections of SARS-CoV-2, its variants (B.1.1.7, B.1.351) and pseudovirus mutants (B.1.1.7, B.1.351, B.1.525, B.1.526 (S477N), B.1.526 (E484K), P.1, P.2, B.1.617.1, B.1.617.2) were decreased. Meanwhile, CD147 antibody effectively blocked the entry of variants and pseudomutants in VeroE6 cells, and inhibited the expression of cytokines. A model of SARS-CoV-2-infected hCD147 transgenic mice was constructed, which recapitulated the features of exudative diffuse alveolar damage and dynamic immune responses of COVID-19. CD147 antibody could effectively clear the virus and alveolar exudation, resolving the pneumonia. We found the elevated level of cyclophilin A (CyPA) in plasma of severe/critical cases, and identified CyPA as the most important proinflammatory intermediate causing cytokine storm. Mechanistically, spike protein of SARS-CoV-2 bound to CD147 and initiated the JAK-STAT pathway, which induced expression of CyPA. CyPA reciprocally bound to CD147, triggered MAPK pathway and consequently mediated the expression of cytokine and chemokine. In conclusion, CD147 is a critical target for SARS-CoV-2 variants and CD147 antibody is a promising drug to control the new wave of COVID-19 epidemic.

immunology↗

Aplp1 and the Aplp1-Lag3 Complex facilitates transmission of pathologic alpha-synuclein

Pathologic -synuclein (-syn) spreads from cell-to-cell, in part, through binding to the lymphocyte-activation gene 3 (Lag3). Here we report that amyloid {beta} precursor-like protein 1 (Aplp1) forms a complex with Lag3 that facilitates the binding, internalization, transmission, and toxicity of pathologic -syn. Deletion of both Aplp1 and Lag3 eliminates the loss of dopaminergic neurons and the accompanying behavioral deficits induced by -syn preformed fibrils (PFF). Anti-Lag3 prevents the internalization of -syn PFF by disrupting the interaction of Aplp1 and Lag3, and blocks the neurodegeneration induced by -syn PFF in vivo. The identification of Aplp1 and the interplay with Lag3 for -syn PFF induced pathology advances our understanding of the molecular mechanism of cell-to-cell transmission of pathologic -syn and provides additional targets for therapeutic strategies aimed at preventing neurodegeneration in Parkinsons disease and related -synucleinopathies. One Sentence SummaryAplp1 forms a complex with Lag3 that facilitates the binding, internalization, transmission, and toxicity of pathologic -synuclein. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=94 SRC="FIGDIR/small/442157v1_ufig1.gif" ALT="Figure 1"> View larger version (35K): org.highwire.dtl.DTLVardef@1d746bforg.highwire.dtl.DTLVardef@65acb2org.highwire.dtl.DTLVardef@12cf2f0org.highwire.dtl.DTLVardef@19d6e_HPS_FORMAT_FIGEXP M_FIG Aplp1 and the Aplp1-Lag3 complex facilitates transmission of pathologic -synuclein. Aplp1 is a receptor that drives pathologic -syn transmission, and genetic depletion of Aplp1 can significantly reduce the -synuclein pathogenesis. Aplp1 and Lag3 forms an Aplp1-Lag3 complex that accounts for substantial binding of pathologic -syn to cortical neurons. Together Aplp1 and Lag3 play a major role in pathologic -syn internalization, transmission and toxicity. Double knockout of Aplp1 and Lag3 and or a Lag3 antibody that disrupts the Aplp1 and Lag3 complex almost completely blocks -syn PFF-induced neurodegeneration. C_FIG

neuroscience↗

Dorsomedial hypothalamic BDNF neurons integrate thermal afferent signals to control energy expenditure

Mutations in the gene brain-derived neurotrophic factor (BDNF) cause obesity in humans. BDNF signaling and its expressing neurons in the hypothalamus help control feeding, energy expenditure (EE), and physical activity. However, whether the BDNF neurons interact with another EE-regulating system, the thermoregulation circuitry, remains unclear. Here, we show that BDNF neurons in the dorsomedial hypothalamus (DMH) are activated by environmental cooling and sufficient to induce body temperature increases and brown adipose tissue (BAT) thermogenesis. Conversely, blocking these neurons impairs BAT thermogenesis and cold defense, causing body weight gain and glucose intolerance. DMH BDNF neurons are therefore an important type of thermoregulatory neuron, integrating thermal afferent signals to control EE during cold defense. This reveals a critical intersection between the BDNF circuitry and the thermoregulatory system.

neuroscience↗

SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

Currently, COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been widely spread around the world; nevertheless, so far there exist no specific antiviral drugs for treatment of the disease, which poses great challenge to control and contain the virus. Here, we reported a research finding that SARS-CoV-2 invaded host cells via a novel route of CD147-spike protein (SP). SP bound to CD147, a receptor on the host cells, thereby mediating the viral invasion. Our further research confirmed this finding. First, in vitro antiviral tests indicated Meplazumab, an anti-CD147 humanized antibody, significantly inhibited the viruses from invading host cells, with an EC50 of 24.86 g/mL and IC50 of 15.16 g/mL. Second, we validated the interaction between CD147 and SP, with an affinity constant of 1.85x10-7M. Co-Immunoprecipitation and ELISA also confirmed the binding of the two proteins. Finally, the localization of CD147 and SP was observed in SARS-CoV-2 infected Vero E6 cells by immuno-electron microscope. Therefore, the discovery of the new route CD147-SP for SARS-CoV-2 invading host cells provides a critical target for development of specific antiviral drugs.

microbiology↗